Trial Profile
A Retrospective, Observational study of Ustekinumab with two different induction regimens (standard versus high dose induction) in patients with Crohn's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jan 2017
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 07 Jan 2017 New trial record